Product Image

Women's Multi Tangerine

MegaFood
4.5
★ ★ ★ ★ ★
(212 ratings)
Iodine 150 mcg
Choline 55 mg
Vitamin K 90 mcg
Product Image
Score72
The women’s gummy provides D3, natural vitamin E, methylcobalamin, vitamin K, iodine, and modest minerals in a convenient format. Carbohydrate, low choline, absent iron, and basic trace-mineral forms leave meaningful gaps.
How scoring works
Quantity:60 Gummy(ies) • (30 servings)
Goals:
Energy
Bone Health
Heart Health
Cardiovascular Support

Score 72

The women’s gummy provides D3, natural vitamin E, methylcobalamin, vitamin K, iodine, and modest minerals in a convenient format. Carbohydrate, low choline, absent iron, and basic trace-mineral forms leave meaningful gaps.
How scoring works
$14.99($0.49 per serving)
Pure Formulas
$ 14.99
iHerb
$ 14.99
iHerb
$ 14.99
Vitacost
$ 14.99
Report prices

Analysis

Vitamin D3, natural vitamin E, methylcobalamin, vitamin K, iodine, zinc, and folate provide broad vitamin-oriented coverage. The formula is designed for broad daily coverage rather than a single nutrient goal.

Choline and zinc are modest, iron is absent, several minerals use basic forms, and the gummy contributes carbohydrate. These gaps materially affect how complete and transparent the product is.

The product best fits adult women seeking an iron-free gummy multivitamin. Diet and any separate supplements still need to cover nutrients that are missing or only partly supplied.

Who is it for
  • Adult women seeking an iron-free gummy multivitamin
  • Users who can review total nutrient intake
  • People seeking broad daily coverage
Best for
  • Convenient vitamin-focused daily support
  • General micronutrient coverage
  • Filling selected dietary gaps

Pros

  • Uses vitamin D3 and methylcobalamin
  • Provides iodine and vitamin K
  • Easy gummy format

Cons

  • No iron, calcium, or magnesium
  • Low choline
  • Contains several grams of carbohydrate

Warnings

  • People who need iron should not rely on this formula for it
  • Vitamin K can conflict with warfarin therapy
  • Review iodine intake with thyroid conditions

Nutrient quality

73 High impact

Vitamin D3 and methylcobalamin are useful, while several trace-mineral and B-vitamin forms are basic. Several vitamins are meaningful, but iron, calcium, and magnesium are absent and choline is modest.

.

Ingredient transparency

81 Highest impact

Active amounts and mineral forms are clearly stated. Complete non-active ingredient details are not included in the supplied label data.

.

Customer satisfaction

67 High impact

The supplied average rating provides limited high-level context. Detailed firsthand feedback is unavailable, so recurring complaints and purpose fit cannot be assessed.

.

Value for money

61 Moderate impact

Convenience supports some value, but major mineral gaps limit quality. The moderate serving cost buys incomplete multivitamin coverage.

.
Report analysis

Goals

Energy
Impact
High effect
B- Goal FitC- Strength of SupportD+ CoverageB Formula Quality
Iodine · 150 mcgVitamin D · 25 mcgRiboflavin · 0.65 mgThiamin · 0.6 mgVitamin B12 · 6 mcg

B vitamins and iodine support normal metabolic and thyroid functions within a women’s gummy multivitamin. Methylcobalamin and potassium iodide provide recognizable forms.

The amounts are mostly maintenance oriented, with vitamin B12 far below the focused energy threshold. The formula lacks mitochondrial, stimulant, and adaptogen ingredients for a stronger energy effect.

Study evidence
Iodine Adverse 3 studies
Bone Health
Impact
Moderate effect
C+ Goal FitC- Strength of SupportD CoverageC Formula Quality
Vitamin K · 90 mcgVitamin D · 25 mcgBoron · 300 mcgZinc · 5 mgVitamin C · 45 mg

Vitamin D3 supports calcium absorption, while a small boron amount adds limited mineral-metabolism support. Vitamin K is K1 rather than K2, and no calcium, magnesium, or collagen is present.

The vitamin D3 amount is useful, but the boron amount is only a minor contribution. Carbohydrate and broad multivitamin ingredients make the gummy more general-purpose than bone-focused.

Study evidence
Boron Supportive 5 studies
Vitamin K Supportive 78 studies
Heart Health
Impact
Moderate effect
D Goal FitC Strength of SupportC CoverageD+ Formula Quality
Vitamin K · 90 mcgVitamin B12 · 6 mcgVitamin B6 · 4 mgFolate · 400 mcg DFEVitamin D · 25 mcg

Vitamin K1, vitamin D, B vitamins, and small antioxidant additions offer general nutritional support, but the gummy is not designed as a heart-focused formula. It lacks the preferred MK-7 form of vitamin K and does not provide major lipid, vascular-tone, or cardiac-energy actives.

The nutrient amounts are disclosed, though several vitamins use basic forms and the heart-relevant ingredients remain modest. Vitamin K1 can oppose warfarin and other vitamin K antagonist medicines, so the gummy may require anticoagulation dose coordination.

Study evidence
Folate Supportive 116 studies
Vitamin D Mixed 164 studies
Vitamin K Mixed 62 studies
Cardiovascular Support
Impact
Moderate effect
C- Goal FitD+ Strength of SupportD+ CoverageD+ Formula Quality
Vitamin K · 90 mcgVitamin D · 25 mcgSelenium · 27.5 mcgVitamin B12 · 6 mcgVitamin B6 · 4 mgVitamin E · 15 mgFolate · 400 mcg DFENiacin · 16 mg NEVitamin C · 45 mg

Vitamin D3, vitamin E, B vitamins, zinc, selenium, and choline provide broad maintenance nutrition with indirect cardiovascular relevance. The gummy lacks focused lipid, vascular-tone, or cardiac-energy ingredients.

Most amounts are suitable for filling everyday gaps rather than materially changing cardiovascular markers. Vitamin K is K1 instead of MK-7, and the gummy base contributes carbohydrate without strengthening the heart-health profile.

Study evidence
Selenium Supportive 107 studies
Vitamin E Mixed 79 studies
Vitamin K Supportive 40 studies

Ingredients

IngredientAmount per serving
Calories
20 Calorie(s)
Total Carbohydrates
5 Gram(s)
Vitamin A (Beta-Carotene)
600 mcg RAE
Vitamin C (Ascorbic Acid)
45 mg
Vitamin D3 (Cholecalciferol)
25 mcg
Vitamin E (D-Alpha-Tocopherol Acetate)
15 mg
Vitamin K (Phytonadione)
90 mcg
Vitamin B1 (Thiamine Mononitrate)
0.6 mg
Vitamin B2 (Riboflavin)
0.65 mg
Niacin (Niacinamide)
16 mg NE
Vitamin B6 (Pyridoxine Hydrochloride)
4 mg
Folate
400 mcg DFE
Vitamin B12 (Methylcobalamin)
6 mcg
Biotin
30 mcg
Choline (Choline Bitartrate)
55 mg
Iodine (Potassium Iodide)
150 mcg
Zinc (Zinc Citrate)
5 mg
Selenium (Sodium Selenate)
27.5 mcg
Chromium (Chromium Chloride)
50 mcg
Molybdenum (Sodium Molybdate)
20 mcg
Sodium
15 mg
Boron (Sodium Borate)
300 mcg
Orange
100 mg
Gluten Free Dairy Free Women 18–50 Vegetarian
Report overview
A+ Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyD+ Value

Potassium iodide provides a stable, well-absorbed source without marine contamination concerns. The 150 mcg amount matches standard daily support needs and remains below the adult upper limit. Moderate cost provides fair value for a clearly dosed multivitamin.

B Active Ingredient Quality & BioavailabilityC Dose, Safety & Label TransparencyF Value

Choline bitartrate is a useful systemic form, but the 55 mg amount is modest for a dedicated choline goal. Two gummies provide the serving and offer moderate daily convenience. The cost per amount of choline is high despite a serving price near the collection norm.

F Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value

Vitamin K is supplied only as K1 phylloquinone rather than vitamin K2. No verified MK-7 dose is available for targeted bone and cardiovascular support. The high-carbohydrate gummy lacks lipid support for absorption, while value is weak because the serving does not provide a verified effective MK-7 dose.

Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women.
    Knapen MH; Drummen NE; Smit E; Vermeer C; Theuwissen E · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Randomized trial244 participantsBone Health forVitamin K
  2. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
    Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2015
    Meta-analysis6,759 participants19 studies pooledBone Health forVitamin K
  3. Investigating the interrelationship of vitamin K and vitamin D status on bone density: results from the VITamin D and OmegA-3 TriaL.
    Chou SH; Booth SL; Cook NR; Kim E; Kotler G; Fu X; Buring JE; Manson JE; LeBoff MS · JBMR plus · 2026
    Randomized trial771 participantsBone Health forVitamin K
  4. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP · Journal of the American Heart Association · 2021
    Cohort study53,372 participantsCardiovascular Support Heart Health forVitamin K
  5. Association of vitamin K with cardiovascular events and all-cause mortality: a systematic review and meta-analysis.
    Chen HG; Sheng LT; Zhang YB; Cao AL; Lai YW; Kunutsor SK; Jiang L; Pan A · European journal of nutrition · 2020
    Meta-analysis222,592 participants21 studies pooledCardiovascular Support forVitamin K
  6. Circulating uncarboxylated matrix Gla protein, a marker of vitamin K status, as a risk factor of cardiovascular disease.
    van den Heuvel EG; van Schoor NM; Lips P; Magdeleyns EJ; Deeg DJ; Vermeer C; den Heijer M · Maturitas · 2014
    Cohort study577 participantsCardiovascular Support forVitamin K
  7. [Comparative study of the urinary excretion of boron, calcium, magnesium and phosphorus in postmenopausal women with and without osteoporosis].
    José Ramón V; Mora Mora M; Marino Alarcón O; Hernández G; Josefina Linares L; Urdaneta Romero H; Arévalo González E · Investigacion clinica · 2013
    Case-control study45 participantsBone Health forBoron
  8. Effect of dietary boron on mineral, estrogen, and testosterone metabolism in postmenopausal women.
    Nielsen FH; Hunt CD; Mullen LM; Hunt JR · FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 1987
    Single-arm trial12 participantsBone Health forBoron
  9. The relationship between boron and magnesium status and bone mineral density in the human: a review.
    Volpe SL; Taper LJ; Meacham S · Magnesium research · 1994
    Narrative reviewBone Health forBoron
  10. Effects of boron supplementation on bone mineral density and dietary, blood, and urinary calcium, phosphorus, magnesium, and boron in female athletes.
    Meacham SL; Taper LJ; Volpe SL · Environmental health perspectives · 1995
    Randomized trial28 participantsBone Health forBoron
  11. Metabolic responses of postmenopausal women to supplemental dietary boron and aluminum during usual and low magnesium intake: boron, calcium, and magnesium absorption and retention and blood mineral concentrations
    C D Hunt, J L Herbel, F H Nielsen · The American Journal of Clinical Nutrition · 1997
    Non-randomized trial11 participantsBone Health forBoron
  12. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials.
    Cockayne S; Adamson J; Lanham-New S; Shearer MJ; Gilbody S; Torgerson DJ · Archives of internal medicine · 2006
    Meta-analysis13 studies pooledBone Health forVitamin K
  13. Effect of combined administration of vitamin D3 and vitamin K2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis.
    Iwamoto J; Takeda T; Ichimura S · Journal of orthopaedic science : official journal of the Japanese Orthopaedic Association · 2001
    Randomized trial92 participantsBone Health forVitamin K
  14. Efficacy and safety of vitamin K2 for postmenopausal women with osteoporosis at a long-term follow-up: meta-analysis and systematic review.
    Zhou M; Han S; Zhang W; Wu D · Journal of bone and mineral metabolism · 2022
    Meta-analysis6,853 participants9 studies pooledBone Health forVitamin K
  15. Low-dose vitamin K2 (MK-4) supplementation for 12 months improves bone metabolism and prevents forearm bone loss in postmenopausal Japanese women.
    Koitaya N; Sekiguchi M; Tousen Y; Nishide Y; Morita A; Yamauchi J; Gando Y; Miyachi M; Aoki M; Komatsu M; Watanabe F; Morishita K; Ishimi Y · Journal of bone and mineral metabolism · 2015
    Randomized trial48 participantsBone Health forVitamin K
  16. Effect of supplementation with high-selenium yeast on plasma lipids: a randomized trial.
    Rayman MP; Stranges S; Griffin BA; Pastor-Barriuso R; Guallar E · Annals of internal medicine · 2011
    Randomized trial501 participantsCardiovascular Support forSelenium
  17. Association of selenium and cadmium with heart failure and mortality based on the National Health and Nutrition Examination Survey.
    Xing X; Xu M; Yang L; Shao C; Wang Y; Qi M; Niu X; Gao D · Journal of human nutrition and dietetics : the official journal of the British Dietetic Association · 2023
    Cohort study15,689 participantsCardiovascular Support forSelenium
  18. Higher serum selenium concentration is associated with lower risk of all-cause and cardiovascular mortality among individuals with chronic kidney disease: A population-based cohort study of NHANES.
    Zhu D; Zhong Q; Lin T; Song T · Frontiers in nutrition · 2023
    Cohort study3,063 participantsCardiovascular Support forSelenium
  19. Selenium status in the body and cardiovascular disease: a systematic review and meta-analysis.
    Kuria A; Tian H; Li M; Wang Y; Aaseth JO; Zang J; Cao Y · Critical reviews in food science and nutrition · 2021
    Meta-analysis13 studies pooledCardiovascular Support forSelenium
  20. Associations of selenium status with all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies.
    Cui Z; Xie R; Lu X; Schomburg L; Brenner H; Schöttker B · Redox biology · 2025
    Meta-analysis95 participants20 studies pooledCardiovascular Support forSelenium
  21. Supplementation with vitamin E alone is associated with reduced myocardial infarction: a meta-analysis.
    Loffredo L; Perri L; Di Castelnuovo A; Iacoviello L; De Gaetano G; Violi F · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2016
    Meta-analysis16 studies pooledCardiovascular Support forVitamin E
  22. Vitamin E ameliorates blood cholesterol level and alters gut microbiota composition: A randomized controlled trial.
    Chen B; Li Y; Li Z; Hu X; Zhen H; Chen H; Nie C; Hou Y; Zhu S; Xiao L; Li T · Nutrition, metabolism, and cardiovascular diseases : NMCD · 2025
    Randomized trial90 participantsCardiovascular Support forVitamin E
  23. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
    Lonn E; Bosch J; Yusuf S; Sheridan P; Pogue J; Arnold JM; Ross C; Arnold A; Sleight P; Probstfield J; Dagenais GR; HOPE and HOPE-TOO Trial Investigators · JAMA · 2005
    Randomized trial9,541 participantsCardiovascular Support forVitamin E
  24. Independent and combined associations of dietary antioxidant exposure with all-cause and cause-specific mortality in the general population.
    Liu Z; He Z; Xing Y · Journal of nutritional science · 2026
    Cohort study34,955 participantsCardiovascular Support forVitamin E
  25. Tocotrienol rich fraction supplementation improved lipid profile and oxidative status in healthy older adults: A randomized controlled study.
    Chin SF; Ibahim J; Makpol S; Abdul Hamid NA; Abdul Latiff A; Zakaria Z; Mazlan M; Mohd Yusof YA; Abdul Karim A; Wan Ngah WZ · Nutrition & metabolism · 2011
    Randomized trial62 participantsCardiovascular Support forVitamin E
  26. Menaquinone-7 supplementation improves arterial stiffness in healthy postmenopausal women. A double-blind randomised clinical trial.
    Knapen MH; Braam LA; Drummen NE; Bekers O; Hoeks AP; Vermeer C · Thrombosis and haemostasis · 2016
    Randomized trial244 participantsCardiovascular Support Heart Health forVitamin K
  27. Effects of One-Year Menaquinone-7 Supplementation on Vascular Stiffness and Blood Pressure in Post-Menopausal Women.
    de Vries F; Bittner R; Maresz K; Machuron F; Gåserød O; Jeanne JF; Schurgers LJ · Nutrients · 2025
    Randomized trial165 participantsCardiovascular Support forVitamin K
  28. Dietary Vitamin K1 Intake and Incident Aortic Valve Stenosis.
    Schultz CJ; Dalgaard F; Bellinge JW; Murray K; Sim M; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Gislason GH; Tjønneland A; Overvad K; Hodgson JM; Bondonno NP · Arteriosclerosis, thrombosis, and vascular biology · 2024
    Cohort study55,545 participantsCardiovascular Support Heart Health forVitamin K
  29. Association between vitamin K1 intake and mortality in the Danish Diet, Cancer, and Health cohort.
    Palmer CR; Bellinge JW; Dalgaard F; Sim M; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Croft KD; Gislason G; Tjønneland A; Overvad K; Schultz C; Lewis JR; Hodgson JM; Bondonno NP · European journal of epidemiology · 2021
    Cohort study56,048 participantsCardiovascular Support Heart Health forVitamin K
  30. Association of radioactive iodine treatment with survivorship symptoms and primary care utilisation in women of reproductive age with thyroid cancer: a retrospective cohort study.
    Devanarayan P; Hartman M; Partin M · Family medicine and community health · 2026
    Cohort study10,882 participantsEnergy forIodine
  31. Energy level and fatigue after surgery for thyroid cancer: A population-based study of patient-reported outcomes.
    Hughes DT; Reyes-Gastelum D; Kovatch KJ; Hamilton AS; Ward KC; Haymart MR · Surgery · 2020
    Cohort study2,584 participantsEnergy forIodine
  32. Health-Related Quality of Life in Differentiated Thyroid Cancer Survivors: A Cross-Sectional Study From Turkey.
    Gültekin A; Kahraman MY; Şengöz T; Şimşek FS · Head & neck · 2026
    Cross-sectional study202 participantsEnergy forIodine
  33. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients.
    Qin X; Li J; Spence JD; Zhang Y; Li Y; Wang X; Wang B; Sun N; Chen F; Guo J; Yin D; Sun L; Tang G; He M; Fu J; Cai Y; Shi X; Ye P; Chen H; Zhao S; Chen M; Gao C; Kong X; Hou FF; Huang Y; Huo Y · Stroke · 2017
    Randomized trial20,702 participantsHeart Health forFolate
  34. Periconception Red Blood Cell Folate and Offspring Congenital Heart Disease : Nested Case-Control and Mendelian Randomization Studies.
    Chen H; Zhang Y; Wang D; Chen X; Li M; Huang X; Jiang Y; Dou Y; Wang Y; Ma X; Sheng W; Jia B; Yan W; Huang G; SPCC (Shanghai Preconception Cohort) Group · Annals of internal medicine · 2022
    Case-control study985 participantsHeart Health forFolate
  35. Intake of vitamin B6, folate, and vitamin B12 and risk of coronary heart disease: a systematic review and dose-response meta-analysis of prospective cohort studies.
    Jayedi A; Zargar MS · Critical reviews in food science and nutrition · 2020
    Meta-analysis369,746 participants11 studies pooledHeart Health forFolate
  36. Folate Biomarkers, Folate Intake, and Risk of Death From All Causes, Cardiovascular Disease, and Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies.
    Fallah M; Karim Dehnavi M; Lotfi K; Aminianfar A; Azadbakht L; Esmaillzadeh A · Nutrition reviews · 2025
    Meta-analysis423,304 participants25 studies pooledHeart Health forFolate
  37. The association between folic acid supplementation and congenital heart defects: Systematic review and meta-analysis.
    Wondemagegn AT; Afework M · SAGE open medicine · 2022
    Meta-analysis37 studies pooledHeart Health forFolate
  38. Vitamin D supplementation for cardiometabolic risk markers in pregnant women based on the gestational diabetes mellitus or obesity status : a randomized clinical trial.
    Yin WJ; Wang P; Ma SS; Tao RX; Hu HL; Jiang XM; Zhang Y; Tao FB; Zhu P · European journal of nutrition · 2024
    Randomized trial1,537 participantsHeart Health forVitamin D
  39. Paricalcitol and endothelial function in chronic kidney disease trial.
    Zoccali C; Curatola G; Panuccio V; Tripepi R; Pizzini P; Versace M; Bolignano D; Cutrupi S; Politi R; Tripepi G; Ghiadoni L; Thadhani R; Mallamaci F · Hypertension (Dallas, Tex. : 1979) · 2015
    Randomized trial88 participantsHeart Health forVitamin D
  40. Vitamin D Supplementation, Serum 25(OH)D Concentrations and Cardiovascular Disease Risk Factors: A Systematic Review and Meta-Analysis.
    Mirhosseini N; Rainsbury J; Kimball SM · Frontiers in cardiovascular medicine · 2020
    Meta-analysis81 studies pooledHeart Health forVitamin D
  41. Does vitamin D supplementation modulate metabolic risk factors of cardiovascular disease? A systematic review and meta-analysis of clinical trials.
    Abumweis S; Alqadi S; Al Tarteer A; Alrefai W; Alzoughool F; Jew S; Qudah T · Asia Pacific journal of clinical nutrition · 2026
    Meta-analysis45 studies pooledHeart Health forVitamin D
  42. Comparative Efficacy of Nutraceuticals on Endothelial Function: A Systematic Review and Network Meta-Analysis.
    Norouzzadeh M; Rashedi MH; Mahdavi-Mazdeh G; Kosari A; Shahinfar H · Current atherosclerosis reports · 2026
    Meta-analysisHeart Health forVitamin D
  43. The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trial.
    Bellinge JW; Francis RJ; Lee SC; Bondonno NP; Sim M; Lewis JR; Watts GF; Schultz CJ · The American journal of clinical nutrition · 2022
    Randomized trial149 participantsHeart Health forVitamin K